Nitroglycerin Infusion Preparation: 25mg/5ml Ampoule
To prepare a nitroglycerin infusion delivering 10-20 mcg/min from a 25mg/5ml ampoule, dilute the entire 5ml ampoule (25mg) into 250ml of D5W or normal saline to create a 100 mcg/ml solution, then infuse at 6-12 ml/hr using non-absorbing (non-PVC) tubing through an infusion pump. 1
Standard Dilution Protocol
Recommended dilution approach:
- Add 25mg (5ml from your ampoule) to 245ml of D5W or 0.9% NaCl to achieve a total volume of 250ml
- This creates a concentration of 100 mcg/ml 1
- Alternative: Dilute 25mg into 495ml for a 50 mcg/ml concentration if fluid restriction is not a concern 1
Critical equipment requirement: You must use non-absorbing (non-PVC) tubing with an infusion pump capable of precise delivery, as PVC tubing absorbs up to 80% of nitroglycerin and requires significantly higher doses 1
Infusion Rate Calculations
For 100 mcg/ml concentration:
- 10 mcg/min = 6 ml/hr
- 20 mcg/min = 12 ml/hr
- Each 1 ml/hr delivers approximately 1.67 mcg/min 1
Starting dose for acute pulmonary edema: Begin at 10-20 mcg/min (6-12 ml/hr with 100 mcg/ml solution) when systolic blood pressure is >110 mmHg 2, 3
Titration Protocol
Initial titration strategy:
- Start at 10 mcg/min (6 ml/hr) using non-absorbing tubing 3, 1
- Increase by 5-10 mcg/min every 3-5 minutes based on blood pressure response and symptom improvement 3, 2
- If no response at 20 mcg/min, increase increments to 10 mcg/min, then 20 mcg/min as needed 3, 1
- Maximum concentration should not exceed 400 mcg/ml 1
For acute pulmonary edema specifically: The European Society of Cardiology recommends starting at 10-20 mcg/min and titrating upward by 5-10 mcg/min every 3-5 minutes until symptoms improve 2, 3
Critical Safety Parameters
Absolute blood pressure thresholds:
- Do not administer if systolic BP <90 mmHg or ≥30 mmHg below baseline 3, 4
- In normotensive patients: maintain systolic BP ≥110 mmHg 3
- In hypertensive patients: do not reduce mean arterial pressure by >25% from baseline 3
- Measure blood pressure every 3-5 minutes during active titration 2
Absolute contraindications:
- Sildenafil use within 24 hours 3, 4
- Tadalafil or vardenafil use within 48 hours 3, 4
- Risk of profound hypotension and death with phosphodiesterase inhibitor interaction 3, 2
Monitoring Requirements
Essential monitoring during infusion:
- Continuous blood pressure and heart rate monitoring 3, 4
- Consider arterial line placement for doses >50-100 mcg/min or borderline blood pressure 2, 4
- Monitor for symptom relief (dyspnea, chest pain) as primary endpoint 4
- Watch for reflex tachycardia, especially at higher doses 3, 2
Common Pitfalls to Avoid
Equipment errors:
- Using PVC tubing instead of non-absorbing tubing will result in massive underdosing and therapeutic failure 1
- Failing to flush or replace infusion set when changing concentrations can delay drug delivery by minutes to hours 1
Dosing errors:
- Starting at 25 mcg/min (the old standard with PVC tubing) when using non-absorbing tubing will cause excessive hypotension 1
- Not inverting the dilution bottle several times to ensure uniform mixing 1
Clinical errors:
- Administering to right ventricular infarction patients who are preload-dependent and will develop profound hypotension 4
- Continuing at low doses (10-20 mcg/min) without adequate titration when blood pressure permits higher doses 5
Duration and Tolerance
Tolerance development:
- Tachyphylaxis typically develops after 24-48 hours of continuous infusion 2, 4
- Periodic dose increases may be necessary to maintain efficacy beyond 24 hours 3
- Transition to oral or topical nitrates when patient remains symptom-free for 12-24 hours 4
Adjunctive Therapy for Pulmonary Edema
Combine nitroglycerin with:
- Non-invasive positive pressure ventilation (BiPAP/CPAP) to improve oxygenation 2
- Loop diuretics (furosemide) for volume overload, though vasodilators are now prioritized 2
- Supplemental oxygen to maintain saturation >90% 2
- Consider beta-blockers in appropriate patients to reduce reflex tachycardia 2
Recent evidence: Higher initial doses (≥100 mcg/min) achieve blood pressure targets faster (hazard ratio 3.5) and may reduce intubation rates in severe presentations, though this requires careful monitoring 5, 6, 7